sec filing
NE
NASDAQ · NEUP
Neuphoria Therapeutics Inc.
Healthcare · Medical - Pharmaceuticals
$3.05
Down-$0.01 (-0.33%)
Updated Nov 2, 2026, 8:59 AM
SID Score
2.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 7.4M
- P/E ratio
- -0.02
- Dividend yield
- 0.00%
- 52-week range
- $3.03 – $5.53
- Volume
- 70.25K
- Avg. volume
- 1.58M
Price performance · NEUP
NEUP price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
NEUP closed at $3.05 after 20 trading sessions, down 11.59% for the selected period.
- Last close
- $3.05
- Period change
- -11.59%
- Period low
- $3.05
- Period high
- $3.48
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $3.10 | $3.11 | $3.04 | $3.05 | 70.25K |
| Oct 29, 2026 | $3.32 | $3.32 | $3.032 | $3.06 | 70.09K |
| Oct 28, 2026 | $3.40 | $3.42 | $3.32 | $3.36 | 38.92K |
| Oct 27, 2026 | $3.48 | $3.48 | $3.38 | $3.39 | 3.64K |
| Oct 26, 2026 | $3.39 | $3.46 | $3.355 | $3.38 | 26.7K |
| Oct 23, 2026 | $3.46 | $3.5899 | $3.37 | $3.44 | 73.02K |
| Oct 22, 2026 | $3.46 | $3.5599 | $3.46 | $3.48 | 4.8K |
| Oct 21, 2026 | $3.49 | $3.54 | $3.465 | $3.48 | 8.8K |
| Oct 20, 2026 | $3.365 | $3.40 | $3.33 | $3.39 | 20.81K |
| Oct 19, 2026 | $3.24 | $3.41 | $3.24 | $3.31 | 39.51K |
| Oct 16, 2026 | $3.35 | $3.41 | $3.24 | $3.30 | 76.42K |
| Oct 15, 2026 | $3.25 | $3.42 | $3.25 | $3.31 | 18.75K |
| Oct 14, 2026 | $3.32 | $3.37 | $3.24 | $3.24 | 45.96K |
| Oct 13, 2026 | $3.49 | $3.49 | $3.32 | $3.39 | 26.64K |
| Oct 12, 2026 | $3.32 | $3.38 | $3.32 | $3.32 | 10.04K |
| Oct 9, 2026 | $3.33 | $3.41 | $3.3201 | $3.36 | 2.52K |
| Oct 8, 2026 | $3.40 | $3.42 | $3.34 | $3.35 | 16.53K |
| Oct 7, 2026 | $3.40 | $3.45 | $3.40 | $3.42 | 4.48K |
| Oct 6, 2026 | $3.45 | $3.50 | $3.43 | $3.45 | 16.46K |
| Oct 5, 2026 | $3.45 | $3.50 | $3.43 | $3.45 | 15.46K |
Latest NEUP news
The latest Smart Investors Daily articles mentioning NEUP.
Stock researchResearch & News · Analysis
Company
Market Activity
Research & News
Loading stock research…